<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><channel><title>eClinical Trials</title><description>
          Bio-IT World: eClinical Trials</description><link>http://www.bio-itworld.com/</link><language>en-us</language><item><title>Integrating Infrastructure for Clinical Trials</title><link>
              http://www.bio-itworld.com/issues/2012/jan/integrating-infrastructure-for-clinical-trials.html</link><description>&lt;p&gt;eClinical Technologies Medidata on the cloud, ‘omics, and personalized medicine. By Kevin Davies January 10, 2012 | Glen de Vries thought he would be teaching biology or chemistry in college, but&lt;/p&gt;</description><pubDate>1/17/2012 8:36:39 AM</pubDate></item><item><title>Survey Says: Tool Up for Smarter Clinical Studies</title><link>
              http://www.bio-itworld.com/2011/11/28/survey-says-tool-up-smater-clinical-studies.html</link><description>&lt;p&gt;&lt;font face="Verdana" size="2"&gt;&lt;strong&gt;Bio-IT World &lt;/strong&gt;| Separate industry surveys by information technology research and advisory firm Gartner and global software company ClearTrial make a strong case for clinical resource management tools in the cost-cutting arsenal of biopharmaceutical and medical device companies. &lt;/font&gt; &lt;/p&gt;
&lt;p&gt; &lt;/p&gt;</description><pubDate>11/28/2011 12:47:59 AM</pubDate></item><item><title>An Insider Perspective on PAREXEL</title><link>
              http://www.bio-itworld.com/2011/11/22/insider-perspective-parexel.html</link><description>&lt;font size="2"&gt;&lt;font face="Verdana"&gt;&lt;strong&gt;Bio-IT World &lt;/strong&gt;| Mark Goldberg, PAREXEL’s chief operating officer, &lt;/font&gt;&lt;/font&gt;&lt;font face="Verdana" size="2"&gt;recently sat down with &lt;em&gt;Bio•IT World &lt;/em&gt;chief editor Kevin Davies to discuss the importance of convergence in Perceptive Informatics’ suite of eClinical offerings, and to share his insights on the future opportunities, trends, and challenges facing the industry. &lt;/font&gt;</description><pubDate>11/22/2011 2:42:51 AM</pubDate></item><item><title>Tooling up for Smarter Studies</title><link>
              http://www.bio-itworld.com/issues/2011/nov-dec/tooling-up-for-smarter-studies.html</link><description>&lt;p&gt;Two industry studies found need for appropriate trial planning and tools. By Deborah Borfitz Novemer 15, 2011 | Separate industry surveys by information technology research and advisory firm Gartner and global software company ClearTrial make a strong case for clinical&lt;/p&gt;</description><pubDate>11/15/2011 11:03:30 PM</pubDate></item><item><title>An Inside Perspective on PAREXEL</title><link>
              http://www.bio-itworld.com/issues/2011/nov-dec/insider-perspective-parexel.html</link><description>&lt;p&gt;One of the oldest clinical research organizations discusses technology and changes in the industry. November 15, 2011 | Mark Goldberg, PAREXEL’s chief operating officer, has been with the company since 1997 when he started the CRO’s medical imaging business. A&lt;/p&gt;</description><pubDate>11/15/2011 3:41:49 AM</pubDate></item><item><title>Seize the New: Laying the Clinical Genomics Pipeline in Wisconsin</title><link>
              http://www.bio-itworld.com/issues/2011/sept-oct/seize-new-laying-clinical-genomics-pipeline-wisconsin.html</link><description>&lt;p&gt;Liz Worthey’s “smart software” crucial to integrating genome sequencing in clinic. By Kevin Davies September 27, 2011 | On Saturday June 27, 2009, a pediatric gastroenterologist named Alan Mayer at the Medical College of Wisconsin (MCW) sat at his computer&lt;/p&gt;</description><pubDate>9/26/2011 11:44:59 PM</pubDate></item><item><title>Trials at the Point-of-Care</title><link>
              http://www.bio-itworld.com/issues/2011/sept-oct/trials-at-point-of-care.html</link><description>&lt;p&gt;Veterans Affairs tries new method for treatment comparison trials. By Deborah Borfitz September 27, 2011 | A new type of clinical trial now undergoing testing at the Veterans Affairs (VA) Boston Healthcare System will likely be of interest to emerging&lt;/p&gt;</description><pubDate>9/26/2011 10:28:44 PM</pubDate></item><item><title>Stigmergy, Anyone?</title><link>
              http://www.bio-itworld.com/issues/2011/sept-oct/stigmergy-anyone.html</link><description>&lt;p&gt;By Ernie Bush September 27, 2011 | The Bush Doctrine | Stigmergy is currently defined in Wikipedia as “A mechanism of indirect coordination between agents or actions. The principle is that the trace left in the environment by an action&lt;/p&gt;</description><pubDate>9/27/2011 1:21:38 AM</pubDate></item><item><title>September-October New Products</title><link>
              http://www.bio-itworld.com/issues/2011/sept-oct/new-products.html</link><description>&lt;p&gt;Versatile NMRAgilent Technologies has announced the release of VnmrJ 3.2, an enhanced version of their software for nuclear magnetic spectroscopy. VnmrJ 3.2 offers a data station version that runs on Windows, Mac, and Linux. This enables users to analyze NMR&lt;/p&gt;</description><pubDate>9/27/2011 1:13:29 AM</pubDate></item><item><title>End of Summer Rant: CDER Must Have Clinical Trial Reform</title><link>
              http://www.bio-itworld.com/issues/2011/sept-oct/CDER-must-have-clinical-trial-reform.html</link><description>&lt;p&gt;By John Russell September 27, 2011 | The Russell Transcript | It’s not always easy to know what to make of FDA initiatives, particularly at the time they are announced. Some are modest and administrative in nature (Fast Track, 2009)&lt;/p&gt;</description><pubDate>9/27/2011 2:10:11 AM</pubDate></item><item><title>Enrollment Modeling Results in Productivity Gains for Merck</title><link>
              http://www.bio-itworld.com/issues/2011/jul-aug/enrollment-modeling-results-productivity-gains-merck.html</link><description>&lt;p&gt;Best Practices Awards 2011 Clinical and Health IT ResearchWinner MerckNominator DecisionViewProject Clinical Enrollment Optimization By Deborah Borfitz August 2, 2011 | Pilot testing DecisionView’s StudyOptimizer provided Merck &amp;amp; Co. with ample evidence that the predictive analytics platform significantly improves the&lt;/p&gt;</description><pubDate>8/1/2011 5:04:57 AM</pubDate></item><item><title>Providing Patients as a Service</title><link>
              http://www.bio-itworld.com/issues/2011/jul-aug/providing-patients-as-service.html</link><description>&lt;p&gt;Best Practices Awards 2011 Judges’ PrizeWinner CliniWorksProject AccelFind By Allison Proffitt August 2, 2011 | Cambridge, Mass. based CliniWorks’ new software as a service platform, AccelFind, allows real time clinical data mining and patient screening from medical records to streamline&lt;/p&gt;</description><pubDate>8/1/2011 5:16:34 AM</pubDate></item><item><title>FDA Works to Become More Transparent</title><link>
              http://www.bio-itworld.com/2011/issues/mar-apr/fda-more-transparent-russell.html</link><description>&lt;p&gt;By John Russell March 29, 2011 | The Russell Transcript | How many genomic data sets were submitted to FDA under the VXDS (voluntary exploratory data submissions) program last year? Is the agency meeting its hiring goals? How many manufacturing&lt;/p&gt;</description><pubDate>3/29/2011 5:20:54 AM</pubDate></item><item><title>Batter Up: A Stratified Approach to Rheumatoid Arthritis</title><link>
              http://www.bio-itworld.com/2011/issues/mar-apr/batter-up-stratified-approach.html</link><description>&lt;p&gt;Centocor focuses on biomarkers for inflammatory diseases, respiratory diseases. &amp;#160; March 29, 2011 | Mark Curran, senior director of immunology biomarkers at Centocor R&amp;amp;D, joined the organization five years ago and was tasked with a broad mission to supply biomarkers&lt;/p&gt;</description><pubDate>3/29/2011 4:32:03 AM</pubDate></item><item><title>Big Pharma Shares Data in Brain Research</title><link>
              http://www.bio-itworld.com/els/2010/06/14/brain-database.html</link><description>&lt;p&gt;&lt;font size="2"&gt;&lt;strong&gt;Reuters&lt;/strong&gt; | Drugmakers have pledged to share data from Alzheimer's and Parkinson's clinical trials in an effort to speed the development of new medicines to treat brain disorders.&lt;/font&gt;&lt;/p&gt;</description><pubDate>6/14/2010 1:16:49 AM</pubDate></item></channel></rss>
